brimonidine

Known as: Brimodine, Brimonidina, 5-bromo-6-(imidazolin-2-ylamino)quinoxaline 
An imidazole derivative and a selective alpha-2 adrenergic receptor agonist. Upon ocular administration, brimonidine acts on the blood vessels… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1990-2018
020406019902018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
PURPOSE To compare the alpha2-adrenergic agonist brimonidine tartrate 0.2% to the beta-adrenergic antagonist timolol maleate 0.5… (More)
Is this relevant?
2006
2006
OBJECTIVE To evaluate the intraocular pressure (IOP)-lowering efficacy and safety of a fixed combination of 0.2% brimonidine… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
OBJECTIVE To estimate the intraocular pressure (IOP) reduction achieved by the most frequently prescribed glaucoma drugs and a… (More)
Is this relevant?
2002
2002
PURPOSE To compare the efficacy and safety of brimonidine-Purite (Alphagan; Allergan, Irvine, CA) 0.15% and 0.2% three times… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
PURPOSE To examine the neuroprotective effect of the alpha(2)-adrenergic agonist brimonidine in a chronic ocular hypertension… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2001
2001
Cold-induced vasoconstriction in cutaneous blood vessels is mediated by increased constrictor activity of vascular alpha2… (More)
Is this relevant?
2000
2000
PURPOSE To report anterior uveitis as a late side-effect of topical brimonidine tartrate 0.2% (Alphagan; Allergan Inc., Irvine… (More)
Is this relevant?
1997
1997
OBJECTIVE Brimonidin tartrate is a highly selective alpha 2-agonist. This study investigates the safety and efficacy of 0.2… (More)
Is this relevant?
1997
1997
BACKGROUND Brimonidine tartrate is a relatively selective alpha2-agonist that effectively reduces mean intraocular pressure (IOP… (More)
Is this relevant?
Highly Cited
1995
Highly Cited
1995
OBJECTIVE To evaluate the mechanism by which brimonidine, a selective alpha 2-adrenergic agonist, lowers intraocular pressure… (More)
Is this relevant?